Pliant Therapeutics Inc (PLRX)
12.85
-0.92
(-6.68%)
USD |
NASDAQ |
Nov 14, 16:00
12.85
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -16.61K% |
| March 31, 2023 | -2.82K% |
| December 31, 2022 | -1.78K% |
| September 30, 2022 | -2.07K% |
| June 30, 2022 | -592.2% |
| March 31, 2022 | -2.25K% |
| December 31, 2021 | -1.23K% |
| September 30, 2021 | -1.68K% |
| Date | Value |
|---|---|
| June 30, 2021 | -1.28K% |
| March 31, 2021 | -1.05K% |
| December 31, 2020 | -426.1% |
| September 30, 2020 | -343.5% |
| June 30, 2020 | -472.2% |
| March 31, 2020 | 38.11% |
| December 31, 2019 | 73.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.61K%
Minimum
Jun 2023
73.91%
Maximum
Dec 2019
-2.17K%
Average
-1.23K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Haemonetics Corp | 9.79% |
| Marker Therapeutics Inc | -- |
| Aligos Therapeutics Inc | -1.52K% |
| Korro Bio Inc | -- |
| CEL-SCI Corp | -- |